Literature DB >> 6766200

Adenocarcinoma of the ethmoid following radiotherapy for bilateral retinoblastoma.

L D Rowe, R Lane, J B Snow.   

Abstract

Adenocarcinoma of the ethmoid sinus is rare, representing only 4-8% of malignancies of the paranasal sinuses. An extraordinary case of papillary adenocarcinoma of the ethmoid sinus arising 30 years following high-dose radiotherapy for bilateral retinoblastoma is presented. Retinoblastoma, though occurring only once in every 23,000 to 34,000 births, is the most common malignant intraocular tumor of childhood. Second fatal mesenchymal and epithelial primaries have been described in 8.5% of patients with bilateral retinoblastomas previously treated with radiotherapy; however, papillary adenocarcinoma arising within the paranasal sinuses has not been reported. Histologically, the findings of a papillary pattern of poorly differentiated, mucicarmine-staining cells enclosing gland-like spaces, and the absence of pseudorosettes, melanin, mesenchymal and peripheral neural elements supports an epithelial origin of this tumor. Agressive treatment including partial maxillectomy, radical pansinusectomy, radical neck dissection followed by regional radiotherapy and systemic chemotherapy failed to prevent the development of fatal hepatic metastases. The high incidence of second fatal primary neoplasms in patients with bilateral retinoblastomas receiving radiation suggests an innate susceptibility that may add to the risk of radiotherapy. Careful long-term head and neck surveillance is mandatory if early aggressive management of these extremely lethal tumors is to be successful.

Entities:  

Mesh:

Year:  1980        PMID: 6766200     DOI: 10.1288/00005537-198001000-00007

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  2 in total

1.  Sinonasal adenocarcinoma: a rare second malignancy in long term retinoblastoma survivors.

Authors:  Pooja Bhagia; Agnes Basas Colanta; David H Abramson; Diane L Carlson; Ruth A Kleinerman; Dennis Kraus; Ira J Dunkel
Journal:  Pediatr Blood Cancer       Date:  2011-05-05       Impact factor: 3.167

2.  Mutational screening of the RB1 gene in Italian patients with retinoblastoma reveals 11 novel mutations.

Authors:  Katia Sampieri; Theodora Hadjistilianou; Francesca Mari; Caterina Speciale; Maria Antonietta Mencarelli; Francesco Cetta; Siranoush Manoukian; Bernard Peissel; Daniela Giachino; Barbara Pasini; Antonio Acquaviva; Aldo Caporossi; Renato Frezzotti; Alessandra Renieri; Mirella Bruttini
Journal:  J Hum Genet       Date:  2006-02-04       Impact factor: 3.172

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.